期刊文献+

噬菌体展示的白色念珠菌热休克蛋白90特异表位在小鼠体内诱发的免疫应答 被引量:3

Immune responses induced by filamentous bacteriophage displayed specific epitope of Candida albicans heat shock protein 90 in mice
下载PDF
导出
摘要 将展示白色念珠菌热休克蛋白(HSP)90特异表位的杂合噬菌体作为抗原免疫C57BL/6J小鼠,以检测该抗原在小鼠体内诱发的体液免疫和细胞免疫.实验结果表明:抗原PA刺激机体产生了较强的抗白色念珠菌HSP90特异性抗体;脾CD4+T和CD8+T淋巴细胞出现率明显增高;脾细胞分泌IL-2的能力有增高趋势.此外,将免疫后的小鼠通过尾静脉进行系统性白色念珠菌感染,采用组织病理学方法观察了抗原对小鼠肾脏白色念珠菌寄居数量的影响,实验结果表明,抗原对系统性白色念珠菌感染具有明显的保护作用.  Immune responses mediated by hybrid-phage expressing specific epitope of Candida albicans heat shock protein 90(PA) in C57BL/6J mice were evaluated in this paper.The results showed that PA induced the specific antibody response against Candida albicans heat shock protein 90,enhanced IL-2 levels and expression of CD4^+T and CD8^+T lymphocytes in spleen.Furthermore,C57BL/6J mice immunized with PA,wild-type phage and TE as a control were infected with live C.albicans by lateral tail vein to detect the protection of PA against systemic candidiasis,and results showed PA-immunized mice had fewer C.albicans cells in the kidneys compared with wild phage-immunized mice and TE-injected mice.Results have demonstrated that PA can induce protective immune responses and may be considered as a potential vaccine candidate.
出处 《东北师大学报(自然科学版)》 CAS CSCD 北大核心 2007年第3期83-87,共5页 Journal of Northeast Normal University(Natural Science Edition)
基金 国家自然科学基金资助项目(30040014 30471602) 吉林省科技发展计划项目(20010416)
关键词 噬菌体展示 白色念珠菌 热休克蛋白90 免疫应答 bacteriophage display Candida albicans HSP90 immune responses
  • 相关文献

参考文献18

  • 1ASHMAN R B,PAPADIMITRIOU J M,OTT A K,et al. Antigens and immune responds in Candida albicans infection [J]. Immunol Cell Biol, 1990,68(1):1-13.
  • 2HAJJEH R A, SOFAIR A N, HARRISON L H, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program [J]. J Clin Microbiol, 2004,42(4):1519-1 527.
  • 3PFALLER M A, DIEKEMA D J, MESSER S A, et al. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents[J]. Infect Dis, 2004,48(2):1-5.
  • 4GUDLAUGSSON O, GILLFSPIE S, LEE K, et al. Attributable mortality of nosocomial candidemia, revisited [J]. Clin Infect Dis, 2003,37(9):1 172-1 177.
  • 5LIN S J, SCHRANZ J, TEUTSCH S M. AspergUlosis case-fatality rate: systematic review of the literature[J]. Clin Infect Dis, 2001,32(3):358-366.
  • 6RICHARDSON M D. Changing patterns and trends in systemic fungal infections[J]. J Antlmicrob Chernother, 2005,56(1):5-11.
  • 7CLARK T A, HAJJEH R A. Recent trends in the epldemiology of invasive mycoses[J]. Curr Opin Infect Dis, 2002,15(6):569-574.
  • 8KRCMERY V, BARNES A J. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance[J]. J Hosp Infect,2002,50(4):243-260.
  • 9PFALLER M A, DIEKEMA D J, MESSER S A, et al. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood[J], J Clin Microblol, 2003,41(1):78-83.
  • 10王桂云,朱筱娟,王丽.噬菌体展示外源多肽的免疫原性研究[J].东北师大学报(自然科学版),2001,33(3):101-104. 被引量:11

二级参考文献12

  • 1王丽,分子科学学报,2000年,16卷,3期,184页
  • 2Huang J S,J Med Coll PLA,1997年,12卷,2期,166页
  • 3Maertens J, Vrebos M, Boogaerts M. Assessing risk factors for systemic fungal infections[J]. Eur J Cancer Care,2001,10(1)56-62.
  • 4Bromuro C,Torosantucci A, Chiani P,et al. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans Vaccine [J]. Infection and Immunity, 2002,70(10):5462-5470.
  • 5Bromuro C, La Valle R, Sandini S, et al. A 70 - Kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis[J]. Infect Immun, 1998, 66 (5): 2154-2162.
  • 6Bystricky S, Paulovicova E, Machova E. Candida albicans mannan-protein conjugate as vaccine candidate[J]. Immunol Lett,2003,85(3) :251 - 255.
  • 7Matthews R, Hodgetts S, Burnie J. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis[J]. J Infect Dis, 1995 ,171(6):1668 - 1671.
  • 8Shadkchan Y, Segal E. Antifungal activity of amphotericin B- lipid admixtures in experimental systemic candidosis in naive mice[J]. J Antimicrob Chemother, 1999,44(6) :787 - 790.
  • 9Cardenas- Freytag L, Cheng E, Mayeux P,et al. Effectiveness of a vaccine composed of heat - killed Candida albicans and a novel mucosal adjuvant, LT(RI92G), against systemic candidiasis[J]. Infect Immun, 1999,67(2):826-833.
  • 10王丽.用丝状噬菌体主要外壳蛋白展示外源多肽的研究[J].科学通报,1998,43(12):1242-1246. 被引量:6

共引文献23

同被引文献55

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部